['healthy']
['telmisartan/amlodipine', 'telmisartan/amlodipine/hctz', 'telmisartan/hctz']

        Inclusion criteria:

          -  Healthy Japanese male subjects age >=20 and <=35 years; body weight: >=50 kg and <=80
             kg; body mass index: >=18.0 and <=25.0 kg/m2

          -  Without any clinically significant findings and complications on the basis of a
             complete medical history, including the physical examination, vital signs (blood
             pressure (BP), pulse rate (PR), body temperature), 12-lead electrocardiograms (ECGs),
             clinical laboratory tests

          -  Signed and dated written informed consent prior to admission to the trial in
             accordance with the Good Clinical Practice (GCP) and the local legislation.

        Exclusion criteria:

        - Any finding of the medical examination (including BP, PR and ECGs) deviating from normal
        and of clinical relevance.
      